Omega Healthcare Investors (NYSE:OHI) Sets New 52-Week High – Time to Buy?

Omega Healthcare Investors, Inc. (NYSE:OHI) hit a new 52-week high on Wednesday . The company traded as high as $49.33 and last traded at $48.8650, with a volume of 130873 shares trading hands. The stock had previously closed at $48.74.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on OHI shares. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Tuesday, April 21st. Bank of America reiterated an “underperform” rating and issued a $46.00 price objective (down from $52.00) on shares of Omega Healthcare Investors in a research note on Tuesday, April 14th. BMO Capital Markets reiterated a “market perform” rating and issued a $52.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, May 4th. Royal Bank Of Canada boosted their price objective on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research note on Monday, May 4th. Finally, Cantor Fitzgerald boosted their price objective on Omega Healthcare Investors from $50.00 to $52.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $49.00.

Omega Healthcare Investors Price Performance

The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. The company has a 50 day moving average price of $46.36 and a 200 day moving average price of $45.51. The firm has a market cap of $14.37 billion, a PE ratio of 23.31, a PEG ratio of 2.19 and a beta of 0.59.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The company had revenue of $322.96 million for the quarter, compared to analysts’ expectations of $264.07 million. During the same quarter last year, the company earned $0.75 EPS. Omega Healthcare Investors’s revenue for the quarter was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Sell-side analysts expect that Omega Healthcare Investors, Inc. will post 3.06 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 5.6%. The ex-dividend date was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio is 129.47%.

Institutional Investors Weigh In On Omega Healthcare Investors

Several large investors have recently modified their holdings of the stock. Mutual Advisors LLC raised its position in Omega Healthcare Investors by 8.5% in the third quarter. Mutual Advisors LLC now owns 327,383 shares of the real estate investment trust’s stock worth $13,321,000 after acquiring an additional 25,565 shares in the last quarter. CPC Advisors LLC purchased a new position in Omega Healthcare Investors in the fourth quarter worth $3,050,000. Bank of New York Mellon Corp raised its position in Omega Healthcare Investors by 6.8% in the third quarter. Bank of New York Mellon Corp now owns 3,761,216 shares of the real estate investment trust’s stock worth $158,799,000 after acquiring an additional 239,134 shares in the last quarter. Bright Futures Wealth Management LLC. purchased a new position in Omega Healthcare Investors in the third quarter worth $458,000. Finally, JPMorgan Chase & Co. raised its position in Omega Healthcare Investors by 77.9% in the third quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock worth $144,278,000 after acquiring an additional 1,496,059 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.